Clinical Outcomes of Single-Step Transepithelial Photorefractive Keratectomy for the Correction of Myopia and Myopic Astigmatism

Purpose. To evaluate the dynamics of functional and refractive outcomes, as well as the safety, efficacy, and predictability of transepithelial photorefractive keratectomy (TransPRK) for the correction of myopia and myopic astigmatism using the SCHWIND Amaris 1050RS laser platform at 1, 3, and 12 months postoperatively.

Materials and Methods. A retrospective study included 186 patients (365 eyes) with a mean age of 29.1 ± 7.75 years and varying degrees of myopia (mean -4.92 ± 2.12 D), with and without myopic astigmatism. All patients underwent single-step TransPRK. Comprehensive ophthalmic examinations were performed preoperatively and postoperatively, including assessment of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and refraction (sphere, cylinder, spherical equivalent), as well as evaluation of efficacy, safety, and predictability. Follow-up examinations were conducted at 1, 3, and 12 months. Statistical analysis was performed using nonparametric methods.

Results. A statistically significant improvement in UDVA and CDVA was observed at all follow-up points compared to preoperative values. At 12 months, UDVA of 1.0 was achieved in 100 % of eyes, and 1.2 in 61 % of eyes. Efficacy and safety indices demonstrated positive dynamics, with no loss of CDVA lines observed in any patient by the end of the follow-up period. High predictability of refractive outcomes was confirmed, with 94 % of eyes within ±0.50 D of the target spherical equivalent at 12 months, and 100 % within ±1.00 D. Astigmatism correction was also highly effective, with a mean residual cylinder of 0.00 D at 12 months postoperatively.

Conclusions. TransPRK using the SCHWIND Amaris 1050RS platform is an effective, safe, and highly predictable method for the correction of myopia and myopic astigmatism. By 12 months, excellent functional and precise refractive outcomes are achieved. Optimal results require thorough preoperative evaluation under standardized conditions, careful surgical planning, and adherence to postoperative management protocols. In the studied cohort, no adjustment of manufacturer-provided nomograms was required to achieve the planned refractive outcomes. 

1. Grzybowski A, Piotr Kanclerz, Kazuo Tsubota, Carla Lanca & Seang-Mei Saw. A review on the epidemiology of myopia in school children worldwide. BMC Ophthalmol. 2020;20(1):27. doi: 10.1186/s12886-019-1220-0.

2. Pan Z, Xian H, Li F, Wang Z, Li Z, Huang Y, Liu W, Li Y, Li F, Wang J, Chen H, Wu Y, Xu Y, Wu G, Zhang Y, He L, Zhang J, Zhang F, Qian X, Zhang X, Zhou L, Feng Y, Li L, He X, Xu X, Yang J, Zhou X, Zhu D, Pan C, Ang M, Saw S-M, Zheng Y, He M, Jonas JB, Bressler NM, Cheng C-Y, Tham Y-C, Zhang C, Wang YX. Myopia and high myopia trends in Chinese children and adolescents over 25 years: a nationwide study with projections to 2050. Lancet Reg Health West Pac. 2025;59:101577. doi: 10.1016/j.lanwpc.2025.101577.

3. Liang JH, Pu Y, Chen J, Liu M, Ouyang B, Jin Z, Ge W, Wu Z, Yang X, Qin C, Wang C, Huang S, Jiang N, Hu L, Zhang Y, Gui Z, Pu X, Huang S, Chen Y. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2025;109(3):362–371. doi: 10.1136/bjo-2024-325427.

4. Barnett V, Barsam A. Update on laser vision correction versus intraocular lens options. Curr Ophthalmol Rep. 2020;8(3):104–110. doi: 10.1007/s40135-020-00242-0.

5. Bohac M, Gulic PM, Biscevic A, Gabric I. Surgical correction of myopia. In: Intraocular Lens. 2019:101. doi: 10.5772/intechopen.85644.

6. Mushkova IA, Maychuk NV, Maychuk DYu, Kishkin YuI, Makarov RA. New methods for diagnosis and treatment of stromal corneal opacities combined with refractive disorders. Modern Technologies in Ophthalmology. 2015;4:172–175.

7. Mushkova IA, Kishkin YuI, Maychuk NV, Ignatiev AV. Improvement of diagnostic and surgical tactics in the correction of post-keratotomy refractive disorders (clinical case). Modern Technologies in Ophthalmology. 2015;4:168–171 (In Russ.).

8. Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol. 1983;96(6):710–715. doi: 10.1016/S0002-9394(14)71911-7.

9. Marshall J. Photoablative reprofiling of the cornea using an excimer laser photorefractive keratotomy. Laser Ophthalmol. 1986;1:21–48.

10. Reinstein DZ, Archer TJ, Gobbe M. The history of LASIK. J Refract Surg. 2012;28(4):291–298. doi: 10.3928/1081597X-20120229-01.

11. Gurnani B, Patel B. Photorefractive keratectomy. StatPearls. 2025.

12. Alio JL, Soria FA, Abbouda A, Peña-García P. Fifteen yearsfollow-up of photorefractive keratectomy up to 10 D of myopia: outcomes and analysis of the refractive regression. Br J Ophthalmol. 2016;100(5):626–632. doi: 10.1136/bjophthalmol-2014-306459.

13. Tenner A, Neuhann TF, Schroder E, Salz JJ, Maguen E. Excimer laser radial keratotomy in the living human eye: a preliminary report. Thorofare (NJ): SLACK Incorporated; 1988:5–8. doi: 10.3928/1081-597X-19880101-04.

14. Pallikaris IG, Papatzanaki ME, Stathi EZ, Frenschock O, Georgiadis. Laser in situ keratomileusis. Lasers Surg Med. 1990;10(5):463–468. doi: 10.1002/lsm.1900100511.

15. Pallikaris IG, Papatzanaki ME, Siganos DS, Tsilimbaris MK. A corneal flap technique for laser in situ keratomileusis: human studies. Arch Ophthalmol. 1991;109(12):1699–1702. doi: 10.1001/archopht.1991.01080120083031.

16. Shortt AJ, Allan BD, Evans JR. Laser-assisted in situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia. Cochrane Database Syst Rev. 2013;(1):CD005135. doi: 10.1002/14651858.CD005135.pub3.

17. Gao H, Miles TP, Troche R, Murdoch DM, Koefoed VF, Cason JB. Quality of vision following LASIK and PRK-MMC for treatment of myopia. Mil Med. 2022;187(9– 10):e1051–e1058. doi: 10.1093/milmed/usab071.

18. Chang JY, Lin P, Hsu C, Catherine Liu CJ. Comparison of clinical outcomes of LASIK, Trans-PRK, and SMILE for correction of myopia. J Chin Med Assoc. 2022;85(2):145–151. doi: 10.1097/JCMA.0000000000000674.

19. Nair S, Kaur M, Sharma N, Titiyal JS. Refractive surgery and dry eye — an update. Indian J Ophthalmol. 2023;71(4):1105–1114. doi: 10.4103/IJO.IJO_3406_22.

20. Chen KY, Chan HC, Chan CM. How effective is keratorefractive lenticule extraction surgery (KLEx) in reducing dry eye outcomes compared to LASIK? A systematic review and meta-analysis. J Refract Surg. 2025;41(8):e839–e854. doi: 10.3928/1081597X-20250506-07.

21. Eskina EN, Parshina VA, Movsesyan MKh, Malakhova AV. Correction of ametropia in patients with posterior corneal elevation. Ophthalmology. 2022;19(3):524–531 (In Russ.). doi: 10.18008/1816-5095-2022-3-524-531.

22. Doga A, Mushkova IA, Kishkin YuI, Maychuk NV, Karimova AN. Five-year results of correction of “super-high” myopia using sub-Bowman femtokeratomileusis with tissue-saving ablation. Modern Technologies in Ophthalmology. 2014;3:129–132 (In Russ.).

23. Semnani F, Damavandi AR, Abdollahi M, Sajadi M, Sadoughi MM, Hassanpour K. Photorefractive keratectomy in patients with thin corneas: systematic review and meta-analysis of clinical outcomes and complications. J Cataract Refract Surg. 2026;52(1):93–103. doi: 10.1097/j.jcrs.0000000000001790.

24. de Ortueta D. TransPRK. In: Cutting Edge of Ophthalmic Surgery: From Childhood Myopia to Robotic Vitrectomy. Springer. 2025:25–37. doi: 10.1007/978-3031-84204-7_2.

25. Gunn DJ, Cox RA. StreamLight single-step transepithelial photorefractive keratectomy (PRK) for myopia and myopic astigmatism. J Ophthalmol. 2024;2024:5597457. doi: 10.1155/2024/5597457.

26. Eskina EN, Maychuk NV, Parshina VA, Kukleva OYu. Medical correction of pathomorphological changes of the ocular surface in patients with intolerance to steroid therapy after photorefractive keratectomy. Annals of Ophthalmology 2019;135(3):67–77 (In Russ.). doi: 10.17116/oftalma201913503167.

27. Reinstein DZ, Archer TJ, Randleman JB. JRS standard for reporting astigmatism outcomes of refractive surgery. J Refract Surg. 2014;30(10):654–659. doi: 10.3928/1081597X-20140903-01.

28. Di Bucchianico A. Coefficient of determination (R²). In: Encyclopedia of Statistics in Quality and Reliability. 2008. doi: 10.1002/9780470061572.eqr173.

29. Shetty R, Narasimhan R, Dadachanji Z, Patel P, Maheshwari S, Chabra A, Roy AS. Early corneal and epithelial remodeling differences identified by OCT imaging and artificial intelligence between two transepithelial PRK platforms. J Refract Surg. 2020;36(10):678–686. doi: 10.3928/1081597X-20200730-03.

30. Sima G, TataruCI, Munteanu M. Evaluation of the efficiency and safety of TransPRK and FS-LASIK refractive procedures on patients with astigmatism and amblyopia. Rom J Ophthalmol. 2023;67(3):267–274. doi: 10.22336/rjo.2023.44.

31. Alhawsawi A, Hariri J, Aljindan M, Alburayk K, Alotaibi HA. Outcomes of single-step transepithelial photorefractive keratectomy compared with alcoholassisted photorefractive keratectomy using WaveLight EX500 platform. Cureus. 2023;15(3):e36872. doi: 10.7759/cureus.36872.

32. Yu J, Zhou H, Chen M, Yu Z , Zhou X, Qian Y. The effects of fixation stability, corneal density, and epithelial hyperplasia on the efficacy of astigmatism correction by transepithelial photorefractive keratectomy. Eye Vis (Lond). 2025;12(1):21. doi: 10.1186/s40662-025-00437-1.

33. Chuprov AD, Pogodina EG, Pligina OV, Fomin AV, Movshev VG, Trubnikov VA. Improvement of TransPRK surgery using the Microscan Visum 1100 Hz system for myopia correction. Laser Medicine. 2023;26(3–4):56–67 (In Russ.). doi: 10.37895/2071-8004-2022-26-3-4-56-67.